Betaxolol
- 1 June 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 100 (6), 943-946
- https://doi.org/10.1001/archopht.1982.01030030951011
Abstract
• The intraocular pressure response to topically instilled 0.25% betaxolol hydrochloride was evaluated in 12 patients with chronic open angle glaucoma or ocular hypertension. The drug produced a significant lowering of IOP in all 12 of the patients under study. A 30% to 35% decrease below baseline IOP was observed and was maintained during the one-year observation period. Visual acuity was stable in all subjects throughout the study and corneal anesthesia was not encountered. Tear secretion was not adversely affected by betaxolol, nor did topical administration of the drug produce any systemic cardiovascular response of consequence. Blood pressure and pulse rate remained stable throughout the year. These data suggest that an ophthalmic formulation of betaxolol may have substantial clinical potential for the treatment of glaucoma.This publication has 7 references indexed in Scilit:
- CLINICAL EXPERIENCE WITH PROPRANOLOL IN THE TREATMENT OF GLAUCOMAActa Ophthalmologica, 2009
- Corneal Anesthesia after Timolol Maleate TherapyAmerican Journal of Ophthalmology, 1979
- Early dose response analysis of ocular hypotensive effects of propranolol in patients with ocular hypertension.British Journal of Ophthalmology, 1976
- Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteersExperimental Eye Research, 1975
- Untoward effects associated with practolol administration: oculomucocutaneous syndrome.BMJ, 1975
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- Effect of dl- and d-propranolol on ocular tension in rabbits and patientsExperimental Eye Research, 1970